Livingston G, Sommerlad A, Orgeta V, Costafreda SG, Huntley J, Ames D, et al. Dementia prevention, intervention, and care. Lancet. 2017;390:2673–734. https://doi.org/10.1016/S0140-6736(17)31363-6.
Li M, Gao Y, Cui J, Li Y, Li B, Liu Y, et al. Cognitive impairment and risk factors in elderly people living in fluorosis areas in China. Biol Trace Elem Res. 2016;172:53–60. https://doi.org/10.1007/s12011-015-0568-0.
Hugo J, Ganguli M. Dementia and cognitive impairment: epidemiology, diagnosis, and treatment. Clin Geriatr Med. 2014;30:421–42. https://doi.org/10.1016/j.cger.2014.04.001.
Knopman DS, Petersen RC. Mild cognitive impairment and mild dementia: a clinical perspective. Mayo Clin Proc. 2014;89:1452–9. https://doi.org/10.1016/j.mayocp.2014.06.019.
International AsD. World Alzheimer’s report 2018. https://www.alz.co.uk/research/world-report-2018. Accessed 7 May 2019. (2019)
Wallin A, Roman GC, Esiri M, Kettunen P, Svensson J, Paraskevas GP, et al. Update on vascular cognitive impairment associated with subcortical small-vessel disease. J Alzheimers Dis. 2018;62:1417–41. https://doi.org/10.3233/JAD-170803.
Jia L, Quan M, Fu Y, Zhao T, Li Y, Wei C, et al. Dementia in China: epidemiology, clinical management, and research advances. Lancet Neurol. 2020;19(1):81–92.
Iadecola C, Duering M, Hachinski V, Joutel A, Pendlebury ST, Schneider JA, et al. Vascular cognitive impairment and dementia: JACC scientific expert panel. J Am Coll Cardiol. 2019;73:3326–44.
Pennisi M, Lanza G, Cantone M, Ricceri R, Spampinato C, Pennisi G, et al. Correlation between motor cortex excitability changes and cognitive impairment in vascular depression: pathophysiological insights from a longitudinal TMS study. Neural Plast. 2016;2016:8154969. https://doi.org/10.1155/2016/8154969.
Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke. 2011;42:2672–713. https://doi.org/10.1161/STR.0b013e3182299496.
Skrobot OA, Black SE, Chen C, DeCarli C, Erkinjuntti T, Ford GA, et al. Progress toward standardized diagnosis of vascular cognitive impairment: guidelines from the vascular impairment of cognition classification consensus study. Alzheimers Dement. 2018;14:280–92.
Verdelho A, Madureira S, Moleiro C, Ferro JM, O'Brien JT, Poggesi A, et al. Depressive symptoms predict cognitive decline and dementia in older people independently of cerebral white matter changes: the LADIS study. J Neurol Neurosurg Psychiatry. 2013;84:1250–4. https://doi.org/10.1136/jnnp-2012-304191.
Devenney E, Hodges JR. The mini-mental state examination: pitfalls and limitations. Pract Neurol. 2017;17:79–80. https://doi.org/10.1136/practneurol-2016-001520.
Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695–9.
Atri A. Imaging of neurodegenerative cognitive and behavioral disorders: practical considerations for dementia clinical practice. Handb Clin Neurol. 2016;136:971–84.
Banerjee G, Jang H, Kim HJ, Kim ST, Kim JS, Lee JH, et al. Total MRI small vessel disease burden correlates with cognitive performance, cortical atrophy, and network measures in a memory clinic population. J Alzheimers Dis. 2018;63:1485–97. https://doi.org/10.3233/JAD-170943.
Smith EE, Beaudin AE. New insights into cerebral small vessel disease and vascular cognitive impairment from MRI. Curr Opin Neurol. 2018;31:36–43. https://doi.org/10.1097/WCO.0000000000000513.
Debette S, Schilling S, Duperron MG, Larsson SC, Markus HS. Clinical significance of magnetic resonance imaging markers of vascular brain injury: a systematic review and meta-analysis. JAMA Neurol. 2019;76:81–94. https://doi.org/10.1001/jamaneurol.2018.3122.
Poggesi A, Pantoni L, Inzitari D, Fazekas F, Ferro J, O'Brien J, et al. 2001-2011: a decade of the LADIS (Leukoaraiosis and DISability) study: what have we learned about white matter changes and small-vessel disease? Cerebrovasc Dis. 2011;32:577–88. https://doi.org/10.1159/000334498.
Pantoni L, Fierini F, Poggesi A. Impact of cerebral white matter changes on functionality in older adults: an overview of the LADIS study results and future directions. Geriatr Gerontol Int. 2015;15(Suppl 1):10–6.
Jokinen H, Koikkalainen J, Laakso HM, Melkas S, Nieminen T, Brander A, et al. Global burden of small vessel disease-related brain changes on MRI predicts cognitive and functional decline. Stroke. 2020;51:170–8. https://doi.org/10.1161/STROKEAHA.119.026170.
Klarenbeek P, van Oostenbrugge RJ, Rouhl RP, Knottnerus IL, Staals J. Ambulatory blood pressure in patients with lacunar stroke: association with total MRI burden of cerebral small vessel disease. Stroke. 2013;44:2995–9. https://doi.org/10.1161/STROKEAHA.113.002545.
Huo YC, Li Q, Zhang WY, Zou N, Li R, Huang SY, et al. Total small vessel disease burden predicts functional outcome in patients with acute ischemic stroke. Front Neurol. 2019;10:808.
Staals J, Makin SD, Doubal FN, Dennis MS, Wardlaw JM. Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden. Neurology. 2014;83:1228–34. https://doi.org/10.1212/WNL.0000000000000837.
Liu Y, Braidy N, Poljak A, Chan DKY, Sachdev P. Cerebral small vessel disease and the risk of Alzheimer's disease: a systematic review. Ageing Res Rev. 2018;47:41–8. https://doi.org/10.1016/j.arr.2018.06.002.
Liang Y, Chen YK, Liu YL, Mok VCT, Ungvari GS, Chu WCW, et al. Cerebral small vessel disease burden is associated with accelerated Poststroke cognitive decline: a 1-year follow-up study. J Geriatr Psychiatry Neurol. 2019;32:336–43. https://doi.org/10.1177/0891988719862630.
Folstein MF, Folstein SE, McHugh PR. "mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–98. https://doi.org/10.1016/0022-3956(75)90026-6.
Lv X, Li W, Ma Y, Chen H, Zeng Y, Yu X, et al. Cognitive decline and mortality among community-dwelling Chinese older people. BMC Med. 2019;17:63.
Pezzotti P, Scalmana S, Mastromattei A, Di Lallo D. The accuracy of the MMSE in detecting cognitive impairment when administered by general practitioners: a prospective observational study. BMC Fam Pract. 2008;9:29.
Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12:822–38. https://doi.org/10.1016/S1474-4422(13)70124-8.
Wu YT, Ali GC, Guerchet M, Prina AM, Chan KY, Prince M, et al. Prevalence of dementia in mainland China, Hong Kong and Taiwan: an updated systematic review and meta-analysis. Int J Epidemiol. 2018;47:709–19. https://doi.org/10.1093/ije/dyy007.
Naqvi TZ, Lee MS. Carotid intima-media thickness and plaque in cardiovascular risk assessment. JACC Cardiovasc Imaging. 2014;7:1025–38. https://doi.org/10.1016/j.jcmg.2013.11.014.
Yagi S, Akaike M, Aihara K, Iwase T, Yoshida S, Sumitomo-Ueda Y, et al. High plasma aldosterone concentration is a novel risk factor of cognitive impairment in patients with hypertension. Hypertens Res. 2011;34:74–8. https://doi.org/10.1038/hr.2010.179.
Alfaro-Acha A, Al Snih S, Raji MA, Kuo Y-F, Markides KS, Ottenbacher KJ. Handgrip strength and cognitive decline in older Mexican Americans. J Gerontol A Biol Sci Med Sci. 2006;61:859–65. https://doi.org/10.1093/gerona/61.8.859.
Graff-Radford J, Madhavan M, Vemuri P, Rabinstein AA, Cha RH, Mielke MM, et al. Atrial fibrillation, cognitive impairment, and neuroimaging. Alzheimers Dement. 2016;12:391–8.
Dong X, Chen R, Simon MA. Elder abuse and dementia: a review of the research and health policy. Health Aff (Millwood). 2014;33:642–9. https://doi.org/10.1377/hlthaff.2013.1261.
Jiang B, Zhang XP, Chen MF, Wang Z, Zhao MX, Chen BH, et al. A cross-sectional study of inpatients with late stage of dementia in Southeast China and the associations between biochemical parameters and apolipoprotein E genotypes. Clin Interv Aging. 2018;13:159–63.
Zhang Y, Guan Y, Shi Z, Yue W, Liu S, Liu S, et al. Sex differences in the prevalence of and risk factors for cognitive impairment no dementia among the elderly in a rural area of northern China: a population-based cross-sectional study. Neuroepidemiology. 2019;52:25–31. https://doi.org/10.1159/000493141.
Bak TH, Mioshi E. A cognitive bedside assessment beyond the MMSE: the Addenbrooke's cognitive examination. Pract Neurol. 2007;7:245–9.
Madureira S, Verdelho A, Moleiro C, Santos C, Scheltens P, Gouw A, et al. White matter changes and cognitive decline in a ten-year follow-up period: a pilot study on a single-center cohort from the Leukoaraiosis and disability study. Dement Geriatr Cogn Disord. 2016;41:303–13. https://doi.org/10.1159/000447121.
Jokinen H, Gonçalves N, Vigário R, Lipsanen J, Fazekas F, Schmidt R, et al. Early-stage white matter lesions detected by multispectral MRI segmentation predict progressive cognitive decline. Front Neurosci. 2015;9:455. https://doi.org/10.3389/fnins.2015.00455.
Poggesi A, Gouw A, van der Flier W, Pracucci G, Chabriat H, Erkinjuntti T, et al. Neurological abnormalities predict disability: the LADIS (Leukoaraiosis and DISability) study. J Neurol. 2014;261:1160–9. https://doi.org/10.1007/s00415-014-7332-9.
Hachinski V. The convergence of stroke and dementia. Arq Neuropsiquiatr. 2018;76:849–52. https://doi.org/10.1590/0004-282x20180148.
Ren L, Zheng Y, Wu L, Gu Y, He Y, Jiang B, et al. Investigation of the prevalence of cognitive impairment and its risk factors within the elderly population in Shanghai, China. Sci Rep. 2018;8:3575.
Zhong G, Wang Y, Zhang Y, Guo JJ, Zhao Y. Smoking is associated with an increased risk of dementia: a meta-analysis of prospective cohort studies with investigation of potential effect modifiers. PLoS One. 2015;10:e0118333. https://doi.org/10.1371/journal.pone.0118333.